Sonnet BioTherapeutics
SONN
SONN
10 hedge funds and large institutions have $158K invested in Sonnet BioTherapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$0 |
3 |
IA
3
IFP Advisors
Tampa,
Florida
|
$0 |
4 |
4
Morgan Stanley
New York
|
$212 |
5 |
5
Citigroup
New York
|
$0 |